
A new review of clinical studies has found that endometriosis is associated with upper gastrointestinal (GI) problems and higher healthcare usage.
Previous research has indicated that endometriosis is associated with upper GI issues. This study compared GI symptoms and health care utilisation in women with and without endometriosis.
The research team conducted a retrospective chart review of adult women with endometriosis compared with women without who presented for evaluation of GI symptoms to an outpatient gastroenterology clinic at a tertiary care hospital.
The results found that females with endometriosis are at three to five times greater risk of developing IBS than healthy women, with rates of IBS as high as 52 per cent, and that 37 per cent of those with IBS also had endometriosis.
The authors write: “Patients with IBS and endometriosis experience lower pain thresholds and more painful menstrual cycles than those with either condition alone. This amplification of pain experiences can increase health care utilization and decrease quality of life.”
They continue: “Once endometriosis is present in the body, it seems to have sustained effects on GI functioning. When digestive symptoms occur alongside gynaecologic symptoms, there may be a delay in diagnosis and treatment.
“Notably, nearly 35 per cent of women with endometriosis in a large sample had diagnostic delays of greater than three years from time of first symptom, and 60 per cent of women saw more than three physicians before being diagnosed, resulting in significantly higher health care costs. In our study, women with overlapping endometriosis had higher rates of health care utilisation across many aspects of care provision.”
The researchers note the study highlights the importance of evaluating for gynaecologic overlap in women presenting with upper GI symptoms including nausea or gastroparesis, and the importance of screening for gynaecologic conditions when evaluating digestive symptoms.
They state: “To reduce health care utilisation, it is essential to reduce time from symptom onset to diagnosis for appropriate treatment.”
Newsletter
Sign up for free weekly updates
The latest femtech news, research and investment, straight to your inbox.









